CLYM
Climb Bio, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsLast reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $147.4M | 20.04% | 0.00% | |
| 2 | FMRFMR | $88.5M | 12.04% | +106049.19% | |
| 3 | UBS GroupUBS | $44.4M | 6.04% | +3861.68% | |
| 4 | BraidwellBraidwell | $36.5M | 4.96% | +82.87% | |
| 5 | Adage Capital Partners GPAdage Capital Partners GP | $32.7M | 4.44% | new | |
| 6 | BlackRockBlackRockindex-like | $30.7M | 4.18% | +486.30% | |
| 7 | T. Rowe Price AssociatesT. Rowe Price | $27.7M | 3.77% | +10.97% | |
| 8 | Cormorant Asset ManagementCormorant | $27.5M | 3.74% | new | |
| 9 | Frontier Capital ManagementFrontier | $25.3M | 3.44% | new | |
| 10 | Vanguard Capital ManagementVanguardindex-like | $22.2M | 3.01% | +44.12% | |
| 11 | Woodline PartnersWoodline Partners | $20.6M | 2.81% | new | |
| 12 | Citadel AdvisorsCitadel | $16.9M | 2.30% | +275.50% | |
| 13 | Redmile GroupRedmile | $16.0M | 2.18% | new | |
| 14 | Great Point PartnersGreat Point Partners | $13.0M | 1.77% | −25.04% | |
| 15 | Affinity Asset AdvisorsAffinity Asset | $12.7M | 1.72% | +38.86% | |
| 16 | Millennium ManagementMillennium | $11.8M | 1.61% | −28.84% | |
| 17 | ADAR1 Capital ManagementADAR1 | $10.7M | 1.46% | +37.64% | |
| 18 | Driehaus Capital ManagementDriehaus | $10.3M | 1.40% | +31.46% | |
| 19 | Geode Capital ManagementGeodeindex-like | $10.2M | 1.39% | +149.90% | |
| 20 | StemPoint CapitalStemPoint Capital | $9.7M | 1.32% | new | |
| 21 | State StreetState Streetindex-like | $9.0M | 1.22% | +420.28% | |
| 22 | Ameriprise FinancialAmeriprise Financial | $8.6M | 1.17% | new | |
| 23 | Parkman Healthcare PartnersParkman Healthcare Partners | $7.3M | 1.00% | new | |
| 24 | Superstring Capital ManagementSuperstring | $6.8M | 0.92% | +161.58% | |
| 25 | Sphera Funds ManagementSphera Funds | $6.3M | 0.86% | +15.38% |
Fund move
No thesis.
Climb Bio, Inc.
9.74
−0.51 · −5.00%
post 9.74 0.00%
108 managers report $735.2M of Climb Bio on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; RA Capital Management is largest at 20.04%.
Expected move
Inputsstraddle ±20.1%
spot 9.74exp Nov 20ATM strike 10ATM straddle 2.30IV 132%